The Case For Softgels: Addressing Stability, Shelf-Life, And Bioavailability Issues In Pharmaceutical Formulation

Softgel formulations offer a solution to stability, shelf-life, and bioavailability challenges in oral medicine. These specialized products require expert knowledge to ensure consistent production quality. With increased drug bioavailability, improved stability and efficacy, and ease of swallowing, softgel products have become increasingly popular.

In addition to these advantages, softgel manufacturing also prioritizes the safety of staff by minimizing exposure to toxic substances. Leveraging a CDMO with expertise and experience in high-quality products can offer sponsor companies a diverse range of softgel products and provide support throughout all stages of drug development.

Finding a partner with a commitment to quality control and compliance is critical for ensuring softgel formulations meet the highest industry standards and regulatory requirements. A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

Considered a key player in the US retinoid drug market, New Zealand-based Douglas CDMO is fast becoming synonymous with excellence in softgel formulations. With their focus on quality control and their reputation for delivering high-quality products, Douglas is the trusted choice for softgel manufacturing. Learn more about Douglas CDMO’s expertise, high-quality products, and commitment to compliance, as well as the advantages of utilizing a softgel formulation for your therapeutic.